The coronary stents market accounted for 74% of the total interventional cardiology devices market in Japan in 2008. It grew at a Compound Annual Growth Rate (CAGR) of 16% during 2001-2008, and was valued at $718m in 2008. The introduction of Drug Eluting Stents (DES) in 2004 by Cordis fuelled growth in the market. In 2008, the DES market accounted for more than 80% of the total coronary stents market. This phenomenal growth was supported by strong clinical evidence showing reduced restenosis rates with DES compared to Bare Metal Stents (BMS).
For further details on this report, please click here:
http://www.global-
Heart disease has emerged as the second major cause of death in Japan in the last few decades, and Coronary Heart Disease (CHD) accounts for approximately half of the heart disease-related deaths in the country. The rise in incidence rate has been largely attributed to socioeconomic development and a growing westernization of lifestyles, including greater availability of high-calorie and high-fat foods, as well as widespread sedentary work patterns coupled with high mental stress. This is one of the factors which has led to a surge in demand for percutaneous procedures. Since the general prognosis of Coronary Artery Disease (CAD) patients in Japan is much better as compared to that in the west, physicians routinely go for PCI as against surgery.
The Japanese market for interventional cardiology devices is dominated by US players. Terumo Corporation, Boston Scientific, Cordis, Medtronic and Abbott Laboratories remain the leading competitors in the Japanese interventional cardiology market. Together, these companies accounted for 90% of the market share in 2008. Local player Terumo is the market leader with 29% market share. Boston Scientific and Cordis dominate the coronary stents market with a combined market share of 42%.
For further details on this report, please click here:
http://www.global-
GlobalData’s “Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth” report is an essential source of data and analysis on the Japanese interventional cardiology market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on five market categories, namely, coronary stent, PTCA balloon, cardiac catheter, coronary guidewire, and arteriotomy closure devices. The report identifies the key trends shaping and driving the dynamism in the Japanese interventional cardiology market. It also provides insight into the prevalent competitive landscape and on the emerging players who are expected to bring significant shifts in the market standing of the existing leaders. In addition, the report analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Japanese interventional cardiology market.
For further details on this report, please click here:
http://www.global-
Or
Visit our report store: www.globaldata.com
